Resveratrol, NAD, and What the Longevity Shelf Isn't Telling You
No corner of the supplement shelf has moved faster, or made larger promises, than the longevity aisle. Resveratrol, NAD precursors and the compounds around them arrive wrapped in language about cellular ageing that would be extraordinary if it were established. Some of the underlying science is genuinely interesting. Very little of it supports the confidence with which these products are sold, and the gap between those two things is what this article is about.
Resveratrol: the compound that started it
Resveratrol is a polyphenol found in grape skins, red wine, Japanese knotweed and a handful of other plants. It became famous through research on sirtuins — a family of proteins involved in cellular regulation — and through the observation that certain interventions extending lifespan in simple organisms appeared to work through related pathways.
That was a legitimate and exciting line of enquiry. What followed was less tidy. Attempts to replicate some of the early findings ran into difficulty, questions were raised about whether resveratrol activates sirtuins directly or through an artefact of the assay used, and the translation from simple organisms to humans has been, to put it mildly, incomplete.
The current honest position: resveratrol is a well-studied antioxidant polyphenol with plausible mechanisms and a research history that is more contested than its marketing suggests. It is not a demonstrated longevity intervention in humans, and anyone selling it as one is well beyond the evidence.
The absorption problem, again
Resveratrol also has the problem this journal keeps returning to. It is poorly bioavailable — absorbed reasonably but then metabolised so rapidly that very little circulates in the free form the research is usually about.
This matters when you read study doses. Amounts used in research are frequently far above what a typical capsule provides, and the amounts present in red wine are lower again by orders of magnitude. The old line about needing to drink an implausible number of bottles to reach a study dose is arithmetic rather than a joke.
Two form details are worth knowing. Trans-resveratrol is the biologically relevant isomer; cis-resveratrol is not, and a product that doesn't specify trans- may contain a mixture. And standardisation matters — an extract stating its trans-resveratrol percentage is telling you something a raw "grape extract" is not.
NAD, and what precursors actually do
The NAD story is more mechanistically solid, which makes the overclaiming around it more frustrating.
NAD+ is a coenzyme central to energy metabolism and to a range of cellular repair processes. Its levels are understood to decline with age. That much is well established and genuinely interesting.
Taking NAD+ itself orally runs into the same wall as oral glutathione: it is a large molecule that doesn't survive digestion intact in useful amounts. So the field turned to precursors — smaller compounds the body can convert into NAD+. Nicotinamide riboside and nicotinamide mononucleotide are the two most discussed, and there is reasonable human evidence that these can raise NAD+ levels measurably.
Here is where the reasoning gets stretched. Raising a biomarker is not the same as producing a health outcome. That NAD+ declines with age, and that a supplement can raise it, does not establish that raising it slows ageing or improves any outcome that matters to you. That step — from marker to benefit — is the one the marketing performs silently and the research has not completed.
It's also worth knowing that NMN's regulatory status as a dietary supplement in the United States has been contested, which is why its availability has been inconsistent. That's a regulatory history rather than a safety finding, but it explains the confusion you may encounter.
Plain niacin, and why nobody mentions it
A detail the category tends to skip: nicotinamide riboside and NMN are not the only routes to NAD+. Ordinary, inexpensive forms of vitamin B3 — niacin and nicotinamide — are also NAD+ precursors, and have been known as such for a very long time.
The premium precursors are argued to have advantages in how they enter the pathway, and there's a real discussion there. But the existence of a cheap alternative that also raises NAD+ is context worth having before paying a substantial premium, and it is conspicuously absent from most longevity marketing.
How to buy in this category without being taken
Four checks. Does the label specify the exact compound and isomer — trans-resveratrol, and which NAD precursor — rather than a vague blend name? Is each ingredient's amount disclosed on its own line, since longevity blends are among the worst offenders for proprietary formulas? Does the brand describe the evidence in measured terms or present early findings as settled? And does the dose bear any relationship to what has actually been studied, or is it a token amount included so the ingredient can appear on the front?
That third check is the most revealing. This category is unusually full of confident language, and a brand willing to say "the human evidence is early" about its own product is signalling something about the rest of its labelling.
How we approach it
Our resveratrol and NAD products name their exact compounds and state each amount on its own line, with no blend obscuring the numbers, and every batch is tested by an independent lab with the certificate for your lot published on the product page.
What we won't do is tell you these compounds will extend your life, because that is not what the evidence shows. They are actively researched compounds with plausible mechanisms and incomplete human data, sold in a category where the language has run considerably ahead of the science. That's a reasonable thing to buy with your eyes open. It is not a reasonable thing to buy because a label implied something the research hasn't demonstrated.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.